0 followers
Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.
Howard Berman
Tempus Labs
16 followers
Adaptive Biotechnologies
13 followers
Twist Bioscience
12 followers
Heligenics
1 follower
Apeel Sciences
5 followers
SOPHiA GENETICS
4 followers
Akoya Biosciences
2 followers
A2 Biotherapeutics
2 followers
Thermo Fisher Scientific
169 followers
Genentech
154 followers
Gilead Sciences
130 followers
Explore companies